CD4-Specific Designed Ankyrin Repeat Proteins Are Novel Potent HIV Entry Inhibitors with Unique Characteristics

Por Schweizer, Andreas, Rusert, Peter, Berlinger, Livia, Ruprecht, Claudia R., Mann, Axel, Corthésy, Stéphanie, Turville, Stuart G., Aravantinou, Meropi, Fischer, Marek, Robbiani, Melissa, Amstutz, Patrick, Trkola, Alexandra
Publicado em 2008

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1

Por Ruprecht, Claudia R., Krarup, Anders, Reynell, Lucy, Mann, Axel M., Brandenberg, Oliver F., Berlinger, Livia, Abela, Irene A., Regoes, Roland R., Günthard, Huldrych F., Rusert, Peter, Trkola, Alexandra
Publicado em 2011

Conformation-Dependent Recognition of HIV gp120 by Designed Ankyrin Repeat Proteins Provides Access to Novel HIV Entry Inhibitors

Por Mann, Axel, Friedrich, Nikolas, Krarup, Anders, Weber, Jacqueline, Stiegeler, Emanuel, Dreier, Birgit, Pugach, Pavel, Robbiani, Melissa, Riedel, Tina, Moehle, Kerstin, Robinson, John A., Rusert, Peter, Plückthun, Andreas, Trkola, Alexandra
Publicado em 2013